Prescription and cumulative oral corticosteroid (OCS) dose for short- and long-term treatments (in prednisolone equivalents, 2015)
| Patients | Female | Age years median (interquartile range) | Total prescriptions per year | Prescriptions per patient and year group mean | Cumulative OCS dose mg per patient per year | Cumulative OCS dose mg per patient per day | |
| Infrequent short-term treatment | 3061 (35.91%) | 56.9% | 59 (48–72) | 3062 | 1.00 | 313 | 0.9 mg |
| Frequent short-term to long-term >180 days | 5463 (64.09%) | 60.5% | 59 (49–71) | 16 607 | 3.04 | 1826 | 5.0 mg |
| Frequent short-term | 934 (10.96%) | 63.0% | 61 (51–72) | 2261 | 2.42 | 771 | 2.1 mg |
| Long-term >20 to ≤90 days | 1871 (21.95%) | 60.5% | 62 (52–72) | 3957 | 2.11 | 1203 | 3.3 mg |
| Long-term >90 to ≤180 days | 1184 (13.89%) | 57.5% | 65 (56–75) | 2870 | 2.42 | 1790 | 4.9 mg |
| Long-term >180 days | 1474 (17.29%) | 57.3% | 69 (59–76) | 7519 | 5.10 | 3314 | 9.1 mg |
| OCS patients total | 8524 (100%) | 59.8% | 61 (49–72) | 19 669 | 2.31 | 1282 | 3.5 mg |